King Sues Intelliject Over EpiPen Patent Violation
King Pharmaceuticals Inc. and a subsidiary are suing Intelliject Inc. for filing a new drug application that they say breaches a patent covering their EpiPen products for allergic reactions....To view the full article, register now.
Already a subscriber? Click here to view full article